Table: Zeria Pharm - 6-MTH group results

Zeria Pharmaceutical

01/11/2023 07:00

Nov 1 (Reuters)- 
             Zeria Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.68               33.71            73.00    
                 (+8.8 pct)          (+17.9 pct)      (+6.8 pct)  
  Operating          5.33                5.89             9.10    
                 (-9.6 pct)         (+120.6 pct)      (+0.9 pct)  
  Recurring          5.50                5.18             9.00    
                 (+6.1 pct)          (+66.3 pct)      (+18.7 pct) 
  Net                5.40                4.00             7.00    
                 (+35.0 pct)         (+89.0 pct)      (+13.0 pct) 
  EPS            122.43 yen           90.41 yen       158.80 yen  
  Ann Div                             40.00 yen        44.00 yen  
  -Q2 div         22.00 yen           18.00 yen                   
  -Q4 div                             22.00 yen        22.00 yen  
  
  NOTE - Zeria Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T